Olivopontocerebellar Atrophy Overview
Learn About Olivopontocerebellar Atrophy
- Olivopontocerebellar atrophy
- OPCA
Puneet Opal is a Neurologist in Chicago, Illinois. Dr. Opal has been practicing medicine for over 37 years and is rated as an Elite provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are Spinocerebellar Ataxia Type 1, Giant Axonal Neuropathy, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.
Tetsuo Ashizawa is a Neurologist in Gainesville, Florida. Dr. Ashizawa is rated as an Elite provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 10, Drug Induced Dyskinesia, and Deep Brain Stimulation. Dr. Ashizawa is currently accepting new patients in some locations.
Massachusetts General Physicians Organization Inc
Jeremy Schmahmann is a Neurologist in Boston, Massachusetts. Dr. Schmahmann is rated as an Elite provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are Spinocerebellar Ataxia, Acute Cerebellar Ataxia, Olivopontocerebellar Atrophy, Drug Induced Dyskinesia, and Gastrostomy. Dr. Schmahmann is currently accepting new patients.
Summary: Spinocerebellar ataxias 27B (SCA27B) is caused by an expansion of ≥ 250 GAA triplets in the FGF14 gene and accounts for 15% of cerebellar ataxias (around 500 patients in France). It is a late-onset form often presenting paroxysmal episodes of ataxia and/or diplopia. The disease progresses slowly, with an average increase of 0.10 points/year on the Friedreich's Ataxia Rating Scale (FARS) - Function...
Background: Spinocerebellar ataxia type 7 (SCA7) is a disease in which people have problems with coordination, balance, speech and vision. It is caused by a change in the ATXN7 gene. A mutation in this ATXN7 gene causes changes in eye cells, which can lead to vision loss. There is no cure for SCA7 but researchers are looking for possible treatments. Researchers need more information about SCA7. They want to c...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center
